Fig 1.
Grouping based on the prescription status of rebamipide.
Non-user = Rebamipide was not co-prescribed during the follow-up period. Continuous-user = Rebamipide was co-prescribed from t0 with the same number of tablets as NSAIDs. Irregular-user = Neither Non-user nor Continuous-user. NSAIDs, non-steroidal anti-inflammatory drugs.
Fig 2.
STROBE diagram illustrating the workflow for patient selection.
STROBE, Strengthening the Reporting of Observational Studies in Epidemiology; LIFE, Longevity Improvement & Fair Evidence; NSAIDs, non-steroidal anti-inflammatory drugs; ICD-10, International Classification of Disease Tenth Revision.
Table 1.
Patient characteristics of cases and controls in this study.
Table 2.
Conditional logistic regression analysis of upper gastrointestinal bleeding.